both male and female rats fed a diet containing 3000 p.p.m. DMA for 2 years (6). In addition, DMA proved to induce To cast light on whether xylazine hydrochloride (XZ), a veterinary medicine commonly used as a sedative agent sister chromatid exchange and to be mutagenic in a gene for food-producing animals, has any promoting potential mutation test using mouse lymphoma cells, although not in for thyroid carcinogenesis, the following studies were perthe Ames test (7-10). Based on these data, there is some formed. In Experiment I, male F344 rats received a diet concern about carcinogenic effects of DMA on consumers via containing 1000 or 0 p.p.m. XZ for 52 weeks with or ingestion of edible tissues in food-producing animals treated without initiation with 2400 mg/kg N-bis(2-hydroxypropyl)-
with xylazine (11). The 47th Joint Food and Agriculture nitrosamine (DHPN). Focal follicular cell hyperplasias, Organization (FAO)/World Health Organization (WHO) Expert adenomas and/or carcinomas were induced in the DHPN
Committee on Food Additives (JECFA) was unable to establish alone, XZ alone and DHPNϩXZ groups, and the incidences an acceptable daily intake (ADI) for XZ, because it was and multiplicities of these lesions in the DHPN⍣XZ group concluded that DMA, its metabolite, was carcinogenic (5). were significantly increased as compared with the DHPN In our previous two-stage nasal carcinogenesis study of alone case. In Experiment II, male F344 rats received a DMA and XZ in rats using N-bis(2-hydroxypropyl)nitrosamine diet containing 1000 or 0 p.p.m. XZ and were examined (DHPN) as an initiator, it was demonstrated that DMA has for serum levels of triiodothyronine (T 3 ), thyroxine (T 4 ) tumor-promoting activity in the rat nasal cavity (12), but that and thyroid-stimulating hormone (TSH) at weeks 1, 2 and this is not the case for XZ, even at a dose of 1000 p.p.m. (13).
In the XZ group, significant increase in thyroid weight
However diffuse follicular cell hypertrophy of thyroid glands and decrease in serum T 4 levels were observed at all was observed in rats administered 1000 p.p.m. XZ for 28 days time points. Serum T 3 and TSH levels were significantly (14) . Since it is well known that thyroid follicular cell decreased and increased, respectively, at week 1, but hypertrophy is produced by continuous serum stimulation of returned to within the control range thereafter. In Experithyroid-stimulating hormone (TSH) (15-17), the possibility ment III, male F344 rats received a diet containing 1000
arises that XZ has tumor-promoting potential in the rat thyroid. or 0 p.p.m. XZ, they were examined for thyroid iodine
The present studies were performed to examine this question uptake and organification of XZ after 1 and 2 weeks. The using a two-stage carcinogenesis model in rats initiated with thyroidal iodine uptake per milligram of thyroid and the DHPN. As a result, thyroid tumors were induced in XZ-treated amount of iodine bound to 1 mg protein showed a tendency rats. Therefore, further studies were conducted to clarify the for decrease at week 1 and significant decrease at week 2. mechanism of action of XZ. These results indicate that XZ has tumor-promoting effects on thyroid follicular cells, and suggest an involvement Materials and methods of alterations in thyroid-related hormone levels due to inhibition of thyroid iodine uptake and organification,
Introduction
Male F344 rats, 4 or 5 weeks old, were purchased from Charles River Japan Xylazine hydrochloride (XZ) is an α 2 -adrenergic agonist with Inc. (Kanagawa, Japan). They were housed, three to five animals per cage, in polycarbonate cages with wood chips for bedding, in an air-conditioned barrier sedative, muscle relaxant and analgesic properties and is system animal room (room temperature 23 Ϯ 2°C; relative humidity 55 Ϯ 5%; air changes, 18 times/h; a 12 h/12 h light/dark cycle). The rats were first Abbreviations: DHPN, N-bis(2-hydroxypropyl)nitrosamine; DMA, 2,6-dimethylaniline; H-E, hematoxylin and eosin; T 3 , triiodothyronine; T 4 , thyroxquarantined for 7 days in the animal room assigned for the study and only those without any abnormal findings were selected for the experiment. Basal ine; TSH, thyroid-stimulating hormone; XZ, xylazine hydrochloride. diet (CRF-1, Oriental Yeast Co., Tokyo, Japan) and tap water were given ad libitum during the acclimatization period.
Experiment I: two-stage thyroid carcinogenesis study A total of 60 5-week-old rats were randomly divided into a DHPN-initiated group of 40 and a non-initiated group of 20 animals. These were given a single subcutaneous injection of 2400 mg/kg of DHPN in physiological saline as vehicle and the vehicle alone, respectively. One week after this initiation treatment, each group of animals was subdivided into two equal groups, receiving no treatment (DHPN alone and control groups) or a pulverized diet Fig. 2 . Follicular cell hyperplasia in the thyroid gland of a rat treated with containing 1000 p.p.m. XZ for 52 weeks (DHPNϩXZ, XZ alone groups). 1000 p.p.m. XZ for 52 weeks after DHPN initiation, showing cystic growth The dose of XZ in this experiment was selected based on the results of our of follicles with increased amount of colloid. H-E staining (ϫ150 previous short-term study, where an increased incidence of follicular cell magnification). hypertrophy was seen in rats given a diet containing 1000 p.p.m. XZ for 28 days (14) . The XZ containing diet was prepared either weekly or fortnightly for determination of thyroidal iodine uptake. The radioactivity of 1 mg thyroid and stored in a refrigerator (temperature, 4°C) before use; the admixture is protein was employed as the parameter for protein-bound iodine. Values were stable at room temperature for only 2 weeks (14) . Body weights and food calculated as percentages of the total radioactivity of the injected Na 125 I. consumption for each group were measured every week during the first 4 weeks and once every 2-6 weeks thereafter. The mean actual intake of XZ Statistical analysis was calculated from the mean body weights and mean food consumption. At Data for body weights and organ weights, multiplicity of thyroid proliferative week 53 after the start, all surviving animals were killed under ether anesthesia lesions, serum thyroid-related hormones and thyroidal iodine uptake and by exsanguination from the abdominal aorta and necropsied. Thyroid glands protein binding iodine are given as mean and standard deviation (SD), and from each group were fixed in 10% neutral buffered formaline, embedded in intergroup differences were analyzed using the Student's t-test. In addition, paraffin, sectioned at 4-5 µm and stained with hematoxylin and eosin (H-E) data for incidences of thyroid proliferative lesions were analyzed using the for light microscopic examination.
Fisher's exact test.
Experiment II: measurement of serum T 3 , T 4 and TSH levels
Based on the results of Experiment I, 42 6-week-old male rats were Results divided into two groups. The initial mean body weights of each group were approximately equal. Twenty-four rats (XZ group) were fed a pulverized diet
Experiment I
containing 1000 p.p.m. of XZ, as described in Experiment I, for 4 weeks.
There were no significant differences in body weight and Eighteen rats were fed a pulverized basal diet alone as the control group. At food consumption between the DHPN-alone and DHPNϩXZ weeks 1, 2 and 4 after the start of experiment, blood was collected from the abdominal aorta of eight rats each from the XZ group and six rats each groups, and between the untreated control and XZ-alone groups from the control group under ether anesthesia for hormone assays. Serum (data not shown). Mean actual intakes of XZ in the DHPNϩXZ triiodothyronine (T 3 ), thyroxine (T 4 ) and TSH were measured by radioimmunoand XZ-alone groups were 56.2 and 53.5 mg/kg/day, assay kit, using a Coat-A-Count Canine T 3 Kit (Diagnostic Products Co., respectively. were killed by exsanguination 24 h after the injection. Thyroid glands were weighed and subjected to iodine uptake studies. The radioactivity of whole acterized by follicular, papillary and/or solid growth of pleorat thyroid glands was measured using a gamma-counter (1480 WIZARD, morphic tumor cells with basophilic cytoplasm and bizarre Wollac, Turku, Finland) . To determine organic 125 I formation for each sample, and/or hyperchromatic nuclei with frequent mitotic figures and the thyroid glands were homogenized individually in 1.0 ml ice-cold solution invasive growth into the surrounding capsule or adjacent tissues of 0.15 M NaCl-1 mM KI, and the protein in homogenates was precipitated (Figure 4) . Furthermore, diffuse follicular cell hypertrophy by the addition of 1.0 ml of 10% trichloroacetic acid and centrifuged for 10 min at 1300 g. The resulting pellet was washed by resuspending in 0.5 ml was observed as a non-focal lesion in the XZ alone and of 5% trichloroacetic acid and recentrifuged for 10 min at 1300 g. Following DHPNϩXZ groups.
the removal of the supernatant, the radioactivity of whole protein-bound 125 I Data for incidence and multiplicity of follicular cell proliferin the pellet was determined using the gamma-counter. The amount of protein ative lesions in each group are summarized in Table I . The in the pellet from each specimen was measured using the method of Lowry et al. (18) . The radioactivity of 1 mg thyroid tissue was used as the parameter incidence and multiplicity of focal follicular cell hyperplasias throughout the treatment period. Absolute and relative thyroid weights were significantly increased in the XZ group as compared with the control group values at all time points.
Relative liver weights at weeks 1 and 2 and absolute and relative weights at week 4 were significantly increased in the XZ group. There were no significant inter-group differences in the pituitary weights at any time point. Serum T 3 , T 4 and TSH concentrations at weeks 1, 2 and 4 are also shown in Table III . Significant decreases in serum T 3 and T 4 and increases in serum TSH levels were observed at week 1 in the XZ group as compared with the control group. The serum T 3 and TSH levels in the XZ group had recovered by week 2, but the serum T 4 level demonstrated a persistent decrease at weeks 2 and 4. Experiment III Thyroid weight and values for iodine uptake and protein corresponding control value at all time points. The thyroidal iodine uptake per milligram of thyroid and the amount of iodine bound to 1 mg protein in the XZ group showed a were 40% and 0.60 Ϯ 0.88 in the DHPN-alone group, 20% and 0.50 Ϯ 1.08 in the XZ-alone group, and 100% and 5.95 tendency to decrease at week 1 and a significant reduction at week 2 as compared with the corresponding control values. Ϯ 1.67 in the DHPNϩXZ group, respectively. Those for adenomas were 10% and 0.10 Ϯ 0.32 in the XZ-alone group, and 60% and 0.80 Ϯ 0.77 in the DHPNϩXZ group, Discussion respectively. Carcinomas were only observed in the It is well known that DHPN has carcinogenic potential in DHPNϩXZ group and their incidence and multiplicity were various organs, including the thyroid gland of rats (19) (20) (21) (22) . It 25% and 0.40 Ϯ 0.82, respectively. In the DHPNϩXZ group, has therefore been used as an initiator for two-stage thyroid the incidence and multiplicity of carcinomas and adenomas carcinogenesis studies, with high incidences of thyroid folliccombined were 60% and 1.20 Ϯ 1.36, respectively. The ular cell tumors developing in goitrogen-treated rats (23) (24) (25) (26) . incidences and multiplicities of these proliferative lesions in
In Experiment I in this study, follicular cell hyperplasias were the DHPNϩXZ group were significantly increased as compared observed in the DHPN-alone, XZ-alone and DHPNϩXZ with those in the DHPN alone group. groups, and adenomas were observed in the XZ-alone and Experiment II DHPNϩXZ groups. Carcinomas were only observed in the DHPNϩXZ group. These proliferative lesions were most Body weight and thyroid, pituitary and liver weights at weeks 1, 2 and 4 after the start of treatment of 1000 p.p.m. XZ are marked in the DHPNϩXZ group. The results strongly suggest that XZ has tumor promotion effects on the rat thyroid gland. shown in Table II . There were consistent, but not statistically significant, decreases in body weight gain in the XZ group
Only weak positive results were obtained in S.typhimurium relatively high concentration in the thyroid gland (4). XZ is metabolized to approximately 20 metabolites, and~8% of the dose was eliminated in the urine as an unchanged compound in the reduction of serum T 4 levels in rats treated with XZ. When XZ was incubated with rat liver microsomes in vitro, activity by directly interfering with the synthesis of thyroid hormones in the thyroid gland (17). Thiourea has been reported strains TA1535 and TA1538 for XZ, and the compound was to cause thyroid follicular cell tumors by the inhibition of negative for mutagenicity in a forward mutation assay with thyroidal iodine uptake and organification followed by decrease cultured mammalian cells and in a mouse bone marrow of serum thyroid hormone levels and the increased stimulation micronucleus test (4). Based on these data, it can be concluded of follicular cells by the ensuing elevation of serum TSH that XZ per se does not have genotoxic potential in vivo.
(17). Therefore, the inhibition of thyroidal iodine uptake and Therefore, the incidence of thyroid follicular cell hyperplasia organification observed in the rats treated with XZ is considered in two rats and an adenoma in one rat might be attributable to be due to the thiourea derivatives that are produced during to spontaneous mutations in follicular cells by continuous TSH the metabolism of XZ. stimulation during long-term treatment of XZ.
In Experiment II in the present study, in spite of the fact It is generally understood that exposure of the rat thyroid that the serum T 4 levels in the XZ group were decreased gland to sustained, elevated levels of serum TSH can lead to significantly as compared with the control group at all time progression through follicular cell hypertrophy and hyperplasia, points, serum T 3 and TSH levels were within the control range eventually to neoplasia (15). Increases in serum TSH levels at weeks 2 and 4. On the other hand, thyroidal iodine uptake can result from a reduction in levels of circulating thyroid per milligram of thyroid and the amount of iodine bound to hormones (T 3 , T 4 ) though the feedback control of the hypothalamus and pituitary gland (16, 17) . A number of important 1 mg protein in the XZ group showed significant decreases at week 2. The question thus arises as to why the serum TSH References level was not increased at weeks 2 and 4. Shimo et al. (25) 1. Greene,S.A. and Thurmon,J.C. (1988) Am. Vet. Med. Assoc., 195, [378] [379] [380] [381] was markedly decreased at week 1 and remained significantly 3. Holland,D.C., Munns,R.K., Roybal,J.E., Hurlbut,J.A. and Long,A.R. (1993) lowered throughout the experiment. Serum TSH levels were Simultaneous determination of xylazine and its major metabolite, 2,6-elevated up to a peak at around week 4 with a return to the dimethylaniline, in bovine and swine kidney by liquid chromatography. normal range at week 12. However, thyroid hypertrophy was J. AOAC Int., 76, 720-724. 4. WHO (1996) Toxicological evaluation of certain veterinary drug residues in present during the treatment period. Okuno et al. (28) involving alteration of thyroid-related hormone levels due to 13. Koujitani,T., Yasuhara,K., Kobayashi,H., Shimada,A., Onodera,H., inhibition of thyroid iodine uptake and organification, resulting Additional studies of XZ using the DHPN initiated two-stage 21. Hiasa,Y., Kitahori,Y., Kitamura,M., Nishioka,H., Yane,K., Fukumoto,M., thyroid carcinogenesis model in rats are now in progress to Nakaoka,S. and Nishii,S. (1991) Relationships between serum thyroid clarify the threshold dose of thyroid tumor-promoting effect stimulating hormone levels and development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine. Carcinogenesis, 12, on this chemical. 873-877. 22. Kitahori,Y., Naito,H., Konishi,N., Ohnishi,T., Shirai,T. and Hiasa,Y. (1995) 
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